semaglutide in louisiana Weight Loss Wednesday: Low-cost weight loss drug banned La TOP 10 BEST Semaglutide in

The findings were published in JAMA Internal Medicine on January 20, showing that glucagon-like peptide-1 (GLP-1) receptor agonists like Ozempic carry an 8.2% higher risk of chronic kidney disease than sodium-glucose cotransporter-2 (SGLT2) inhibitors

SAFETY AND EFFICACY CONCERNS RAISED BY THE FDA, AUSTRALIAN GOVERNMENT, AND BIG PHARMA AFTER FIVE DIE ON COMPOUNDED GLP-1 DRUGS, AND OTHERS REPORT SERIOUS SIDE EFFECTS Despite allowing compounding, the FDA has expressed concerns about GLP-1 knockoffs

doi:10.1186/s12933-025-02739-z 63

doi: 10.3390/biom12111640 125

GLP-1 therapy is an adjunct or a stepping stone, not a replacement when your airway anatomy is the problem